Drug Type Therapeutic vaccine, mRNA vaccine |
Synonyms- |
Target |
Mechanism TYRP2 inhibitors(dopachrome tautomerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | 23 Aug 2022 |